Brief: Incannex Complete Successful Pre-IND Meeting with the FDA for CannQuit-O for treatment of opioid use disorder
07/05/2024 12:48
May 7 (Reuters) - Incannex Healthcare Inc IXHL.O :
* INCANNEX COMPLETE SUCCESSFUL PRE-IND MEETING WITH THE FDA
FOR
CANNQUIT-O FOR TREATMENT OF OPIOID USE DISORDER
Source text for Eikon: ID:nGNX44qFP8
Further company coverage: IXHL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Incannex Healthcare
See all newsIncannex Healthcare Inc reports results for the quarter ended June 30 - Earnings Summary
Incannex Healthcare Inc expected to post a loss of 75 cents a share - Earnings Preview
Brief: Incannex Receives Additional A$5.1 Million Research And Development Tax Incentive Refund
Brief: Incannex Healthcare Commences DReAMzz Clinical Study Of IHL-42X For Obstructive Sleep Apnea
Brief: Incannex Reactivates Share Repurchase Program, Underscoring Confidence In Valuation And Strategic Position